- Citations, last 5 years
- 40
- Works, last 5 years
- 11
- h-index
- 23
- Scientists listed
- 1
- Grants since 2016
- 30
Grants received
2024–2026 · cooperative agreement · Cooperative Agreement
SBIR Phase II: Re-envisioning alt text for education through concurrent authoring and diagram design
Julia Winter · Alchem Laboratories (United States) · funded by National Science Foundation
2023–2024 · research · R43
Multisensory Augmented Reality as a bridge to audio-only accommodations for inclusive STEM interactive digital media
Julia Winter · Alchem Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N02
SYNTHESIS OF NON-GMP SMALL MOLECULES Base Year Increment 1
James Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N02
SYNTHESIS OF NON-GMP SMALL MOLECULES Base Year Increment 2
James D Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2022 · contract · N02
THE NON-GMP SYNTHESIS OF 100 GRAMS OF (R)-N-(6-CHLORO-4-((1-PHENYLETHYL)AMINO)PYRIDO[3,4-D]PYRIMIDIN-5-YL)METHANE-SULFONAMIDE (MTX-531)
James Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2022–2025 · contract · N02
SYNTHESIS OF NON-GMP SMALL MOLECULES Base Year Increment 2
James D Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N02
SYNTHESIS OF NON-GMP SMALL MOLECULES Base Year Increment 1
James Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2022–2026 · contract · N02
SYNTHESIS OF NON-GMP SMALL MOLECULES
James D Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2021 · contract · N01
Preclinical Services for HIV Therapeutics: QA/QC Plan and Task Order Initiation Meeting
James Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2021–2022 · contract · N02
SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR (CONTINUITY FOR 66C)
James Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2021–2023 · contract · N02
SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR (Option Yr 1)
James Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2021–2024 · contract · N02
SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR (Option Yr 1)
James Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2021–2025 · contract · N02
SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR (Option Yr 3)
James Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2021–2025 · contract · N02
SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR
James Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2019–2024 · contract · N02
DFMC- THE PURPOSE OF THIS TASK ORDER IS TO MANUFACTURE AND DELIVER 2200 CAPSULES OF 4MG AZA-TDC (5-AZA-4-THIO-2-DEOXYCYTIDINE)
Jim Talton · Alchem Laboratories (United States) · funded by National Institutes of Health
2018 · contract · N02
IGF::OT::IGF SYNTHESIS OF 30 GRAMS OF THE TARGET COMPOUND, TASK ORDER PERIOD OF PERFORMANCE: 2/28/2018-4/27/2018.
Mianji Zhang · Alchem Laboratories (United States) · funded by National Institutes of Health
2018 · contract · N02
IGF::OT::IGF FOR SYNTHESIS OF 30 GRAMS OF THE TARGET COMPOUND, TASK ORDER HHSN26100003. TO PERIOD OF PERFORMANCE: 2/28/2018-5/25/2018
Mianji Zhang · Alchem Laboratories (United States) · funded by National Institutes of Health
2017–2021 · contract · N01
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
Sergiy Denysenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N02
IGF::OT::IGF Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
Sergiy Denysenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2017 · contract · N02
IGF::OT::IGF Task Order #1 "Kickoff Meeting with NCI Staff" POP: 9/18/17-10/17/17
Mianji Zhang · Alchem Laboratories (United States) · funded by National Institutes of Health
2017–2020 · contract · N01
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
Sergiy Denysenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2017–2019 · contract · N02
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
Sergiy Denysenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
Sergiy Denysenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2017–2020 · grant · Standard Grant
SBIR Phase II: Game-Based Learning for Organic Chemistry Using Mechanisms
Julia Winter · Alchem Laboratories (United States) · funded by National Science Foundation
2017–2018 · contract · N02
IGF::OT::IGF Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
Sergiy Denysenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2016–2018 · contract · N02
IGF::OT::IGF NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT
Vladimir Rudchenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N02
IGF::OT::IGF NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT
Vladimir Rudchenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2016–2019 · contract · N02
NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT
Vladimir Rudchenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2016–2021 · contract · N02
NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT
Vladimir Rudchenko · Alchem Laboratories (United States) · funded by National Institutes of Health
2016–2020 · contract · N02
NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT
Vladimir Rudchenko · Alchem Laboratories (United States) · funded by National Institutes of Health
